NuVasive Announces First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
NuVasive (NUVA) PT Raised to $80 at Needham & Company
May 6, 2021 6:58 AM EDTNeedham & Company analyst Mike Matson raised the price target on NuVasive (NASDAQ: NUVA) to $80.00 (from $70.00) while maintaining a Buy rating.
The analyst commented, "NUVA's 1Q21 revenue and EPS beat consensus and revenue growth improved from the prior quarter. Adjusting for comps, we... More
NuVasive (NUVA) Tops Q1 EPS by 2c
May 5, 2021 5:10 PM EDTNuVasive (NASDAQ: NUVA) reported Q1 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $271.2 million versus the consensus estimate of $261.77 million.
"NuVasive delivered year-over-year growth in the U.S. and international markets, and I am encouraged by the... More
